Randomized Placebo-Controlled Trial of 2,3-Dimercaptosuccinic Acid in Therapy of Chronic Arsenicosis Due to Drinking Arsenic-Contaminated Subsoil Water
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 36 (7) , 683-690
- https://doi.org/10.3109/15563659809162616
Abstract
Introduction: Chronic arsenic toxicity producing various clinical manifestations is currently epidemic in West Bengal, India, Bangladesh, and other regions of the world. Animal studies have indicated that 2,3-dimercaptosuccinic acid can be used as an oral chelating agent. A prospective, double-blind, randomized controlled trial was carried out to evaluate the efficacy and safety of 2,3-dimercaptosuccinic acid for chronic arsenicosis due to drinking arsenic-contaminated (≥ 50 μg/L) subsoil water in West Bengal. Method: Twenty-one consecutive patients with chronic arsenicosis were individually randomized (random number; assignment made by individual not evaluating patients) into 2 groups: 11 patients (10 male, age 25.5±8 years) received 2,3-dimercaptosuccinic acid 1400 mg/d (1000 mg/m2) in the first week and 1050 mg/d (750 mg/m2) during the next 2 weeks with a repeat course 3 weeks later. The other 10 patients (all male, age 32.2±9.7 years) were given placebo capsules for the same schedule. The clinical features were evaluated by an objective scoring system before and after treatment. Routine investigations including liver function tests, arsenic concentrations in urine, hair, and nails, and skin biopsy evaluations were also completed. Results: Though there was improvement in the clinical score of 2,3-dimercaptosuccinic acid-treated patients, similar improvement was observed in the placebo-treated group. There were no statistical differences in the clinical scores between the 2 groups at the beginning and at the end of treatment. Similarly, no differences were found for the other investigated parameters. Conclusion: Under the conditions of this study, 2,3-dimercaptosuccinic acid was not effective in producing any clinical or biochemical benefit or any histopathological improvement of skin lesions in patients with chronic arsenicosis.Keywords
This publication has 17 references indexed in Scilit:
- Groundwater arsenic contamination in Bangladesh and West Bengal, India.Environmental Health Perspectives, 2000
- Non-cancer effects of chronic arsenicosis with special reference to liver damagePublished by Springer Nature ,1997
- Organ-Specific Therapeutic InterventionPublished by Elsevier ,1995
- Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected peopleThe Analyst, 1995
- Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxide poisoning in miceArchives of Toxicology, 1993
- Efficacy of Dimercapto Chelatin Agents for the Treatment of Poisoning by Percutaneously Applied Dichloro(2-chlorovinyl)arsine in RabbitsHuman & Experimental Toxicology, 1993
- Efficacy of various dithiol compounds in acute As2O3 poisoning in miceArchives of Toxicology, 1990
- Evaluation of the Efficacy of Dimercapto Chelating Agents for the Treatment of Systemic Organic Arsenic Poisoning in RabbitsHuman & Experimental Toxicology, 1990
- Arsenic in the drinking water of the city of Antofagasta: epidemiological and clinical study before and after the installation of a treatment plantEnvironmental Health Perspectives, 1977
- British Anti-Lewisite (BAL)Nature, 1945